Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
157 participants
OBSERVATIONAL
2018-05-01
2022-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Outcomes of Endovascular Revascularization in CLTI in Patients Associated With Heel Ulcers
NCT05570968
Endovascular Therapy in Patients With Acute Deep Vein Thrombosis
NCT05827120
Simplification of the Diagnosis of Deep Vein Thrombosis
NCT01412242
The Clinical Application of Infrared Thermal Imaging Detecting Venous Thromboembolism
NCT02552420
Post-Market Evaluation of Active Thrombectomy and Proximal Aspiration During Lower Extremity Tibial Interventions
NCT06929832
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The objectives of this study include Primary: To determine the success rate of target lesion revascularisation using endovascular limb salvage techniques in Critical limb ischemia patients with minor and major tissue loss.
Secondary objectives included:
1. to compare and contrast limb salvage rate to international standards
2. to assess the maintenance of amputation-free survival and bipedal ambulation
3. to evaluate the angiosome concept and its effect on wound healing
4. to evaluate primary patency rate
5. to assess the overall morbidity and mortality of endovascular treatment for critical limb ischemia
6. to observe the outcomes of various wound healing techniques and its efficacy
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Critical Limb ischemia patients with tissue loss
CLI patients with minor and major tissue loss who had endovascular revascularisation
Endovascular revascularisation
Peripheral vascular angioplasty or stenting
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Endovascular revascularisation
Peripheral vascular angioplasty or stenting
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
33 Years
89 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Naveen Seecheran
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Naveen Seecheran
Senior Lecturer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Eric Williams Medical Sciences Complex
Port of Spain, North Central, Trinidad and Tobago
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Harnanan D, Parbhu S, Pran L, Baboolal I, Harnarayan P, Naraynsingh V, Seecheran N. Endovascular Revascularization and Outcomes of Critical Limb-Threatening Ischemia in Trinidad and Tobago: The EVENT Pilot Study-Challenges in a Limited-Resource, Caribbean Setting. Cardiol Ther. 2023 Sep;12(3):511-524. doi: 10.1007/s40119-023-00322-9. Epub 2023 Jun 17.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CEC175/04/17
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.